Melcor Developments Ltd. (TSX:MRD)
Canada · Delayed Price · Currency is CAD 14.30
-0.03 (-0.21%)
Aug 1, 2025, 4:00 PM EDT
CTI BioPharma Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 25.76 | 33.53 | 62.98 | 89.35 | 56.31 | 11.46 | Upgrade |
Depreciation & Amortization | 1.22 | 1.25 | 1.26 | 1.35 | 1.33 | 1.41 | Upgrade |
Other Amortization | 5.57 | 8.22 | 8.42 | 7.56 | 8.16 | 7.88 | Upgrade |
Loss (Gain) From Sale of Assets | -0.01 | -0.06 | -0.05 | -0.04 | -0.15 | -0.04 | Upgrade |
Asset Writedown & Restructuring Costs | 15.51 | 28.44 | 24.46 | -21.55 | -19.37 | 76.48 | Upgrade |
Stock-Based Compensation | 1.26 | 1.24 | 1.06 | 0.84 | 1.13 | 0.87 | Upgrade |
Other Operating Activities | 38.96 | 21.29 | -13.85 | -19.21 | 33.05 | -47.43 | Upgrade |
Change in Accounts Receivable | 1.81 | -31.34 | -28.84 | 30.51 | -54.4 | 3.07 | Upgrade |
Change in Inventory | 35.7 | 40.5 | 7.28 | -48.89 | 32.05 | 16.66 | Upgrade |
Change in Other Net Operating Assets | 2.22 | -4.44 | -13.9 | -21.56 | 14.71 | -17.24 | Upgrade |
Operating Cash Flow | 127.98 | 98.63 | 48.81 | 18.35 | 72.82 | 53.12 | Upgrade |
Operating Cash Flow Growth | 129.60% | 102.07% | 165.97% | -74.80% | 37.09% | 70.12% | Upgrade |
Capital Expenditures | -0.52 | -0.93 | -0.72 | -0.74 | -1.22 | -1.06 | Upgrade |
Sale of Property, Plant & Equipment | 0.01 | 0.13 | 0.07 | 0.07 | 0.28 | 0.05 | Upgrade |
Sale (Purchase) of Real Estate | 53.35 | 7.51 | 4.29 | 18.99 | -16.74 | -16.41 | Upgrade |
Investment in Securities | -3.22 | -3.77 | - | - | - | - | Upgrade |
Other Investing Activities | - | -0.25 | 1 | - | - | - | Upgrade |
Investing Cash Flow | 49.63 | 2.69 | 4.64 | 18.33 | -17.68 | -17.41 | Upgrade |
Long-Term Debt Issued | - | 37.4 | 24.44 | 146.61 | 149.73 | 64.23 | Upgrade |
Long-Term Debt Repaid | - | -101.46 | -95.55 | -123.78 | -156.09 | -94.86 | Upgrade |
Net Debt Issued (Repaid) | -130.23 | -64.06 | -71.11 | 22.83 | -6.37 | -30.63 | Upgrade |
Issuance of Common Stock | - | - | - | 0.03 | 0.22 | - | Upgrade |
Repurchase of Common Stock | -4.44 | -4.33 | -8.1 | -21.46 | -3.88 | -1.31 | Upgrade |
Common Dividends Paid | -13.37 | -13.4 | -19.76 | -18.66 | -14.53 | -11.27 | Upgrade |
Other Financing Activities | -1.32 | -0.3 | - | - | - | - | Upgrade |
Financing Cash Flow | -149.36 | -82.09 | -98.97 | -17.26 | -24.56 | -43.22 | Upgrade |
Foreign Exchange Rate Adjustments | 0.3 | 0.42 | -0.25 | 1.12 | 0.13 | -0.27 | Upgrade |
Net Cash Flow | 28.56 | 19.65 | -45.78 | 20.55 | 30.72 | -7.78 | Upgrade |
Free Cash Flow | 127.46 | 97.7 | 48.09 | 17.62 | 71.6 | 52.06 | Upgrade |
Free Cash Flow Growth | 133.35% | 103.15% | 172.99% | -75.40% | 37.53% | 71.90% | Upgrade |
Free Cash Flow Margin | 36.37% | 27.95% | 15.25% | 7.29% | 22.69% | 22.95% | Upgrade |
Free Cash Flow Per Share | 4.12 | 3.18 | 1.55 | 0.54 | 2.15 | 1.56 | Upgrade |
Cash Interest Paid | 33.2 | 33.96 | 35.24 | 30.98 | 31.45 | 31.96 | Upgrade |
Cash Income Tax Paid | 21.3 | 14.52 | 12.62 | 24.52 | 13.56 | 9.95 | Upgrade |
Levered Free Cash Flow | 143.09 | 48.5 | 45.67 | 31.44 | 43.5 | 58.06 | Upgrade |
Unlevered Free Cash Flow | 158.65 | 65.17 | 62.81 | 46.6 | 57.79 | 73.71 | Upgrade |
Change in Net Working Capital | -70.32 | 24.21 | 21.84 | 21.94 | 25.49 | -14.63 | Upgrade |
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.